The Lancet Infectious Diseases journal reports the findings of a study of a host blood signature of TB that differentiated between people who had or would develop active TB and those who remained healthy, and investigated in parallel the effect of giving TB preventive therapy based on a positive signature result.
Professor Tom Scriba has written an opinion piece for News24 in which he explains the safety profile of the 3 available COVID-19 vaccines & the benefits of receiving it.
Associate Professor Elisa Nemes has been appointed full member of the Institute of Infectious Disease and Molecular Medicine at the UCT Health Sciences Faculty.
The results from the ID93+GLA-SE TB vaccine clinical trial have just been published in the Lancet Respiratory Medicine journal. The candidate vaccine displayed an acceptable safety profile and provides encouraging evidence of vaccine-induced immune responses when given to cured TB patients at the end of treatment.